PE20021035A1 - Composiciones que contienen imidazotriazinona para administracion nasal - Google Patents
Composiciones que contienen imidazotriazinona para administracion nasalInfo
- Publication number
- PE20021035A1 PE20021035A1 PE2002000303A PE2002000303A PE20021035A1 PE 20021035 A1 PE20021035 A1 PE 20021035A1 PE 2002000303 A PE2002000303 A PE 2002000303A PE 2002000303 A PE2002000303 A PE 2002000303A PE 20021035 A1 PE20021035 A1 PE 20021035A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- local anesthetic
- formula
- halogen
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA COMPOSICION NASAL QUE COMPRENDE i)UN INHIBIDOR DE FOSFODIESTERASA DE 3',5'-MONOFOSFATO DE GUANOSIN CICLICA PDE GMPc, TAL COMO IMIDAZOTRIAZINONAS DE FORMULA I DONDE R1 ES H, ALQUILO C1-C4; R2 ES ALQUILO C1-C4; R3 Y R4 SON ALQUILO C1-C5 OPCIONALMENTE SUSTITUIDo CON HIDROXI, METOXI O JUNTO A N FORMAN PIPERIDINILO, MORFOLINILO, TIOMORFOLINILO, PIPERAZINA SUSTITUIDO CON R7; R7 ES H, FORMILO, ACILO, ALCOXICARBONILO, ENTRE OTROS; R5 Y R6 SON H, ALQUILO C1-C6, OH, ALCOXI C1-C6; SON COMPUESTOS PREFERIDOS 2-[2-ETOXI-5-[(4-ETILPIPERAZIN-1-IL)SULFONIL]FENIL]-5-METIL-7-PROPIL-IMIDAZO[5,1-f][1,2,4]TRIAZIN-4(3H)-ONA; UTILIZANDO DE 0,5g/Kg A 200 g/Kg; ii)UN ANESTESICO LOCAL TAL COMO a)UN COMPUESTO DE FORMULA II, R1 ES H, NH2, NH(ALQUILO C1-C6), O-ALQUILO C1-C6, CH2OPh; R2 ES (CH2)(1-6)-HET, O-ALQUILO C1-C6; R3 ES H, HALOGENO, ALQUILO C1-C6; b)UN COMPUESTO DE FORMULA III, R1 ES H, OH; R2 ES ALQUIL C1-C6-N-(ALQUILO C1-C6)2; R3 ES ALQUILO C1-C6, HALOGENO, COO-ALQUILO C1-C6; ENTRE OTROS; n ES 1-2; c)LIDOCAINA, BENZOCAINA, TETRACAINA, BENOXINATO, POLIDOCANOL, BUTAMBEN, PIPEROCAINA, PROCAINA, CLOROPROCAINA, ENTRE OTROS, UTILIZANDO UNA CONCENTRACION MENOR DEL 4%; CON LA CONDICION QUE EL ANESTESICO LOCAL NO ES ALCOHOL BENCILICO; iii)DISOLVENTE O COADYUVANTES COMO TAMPONES, SUSTANCIAS POTENCIADORAS DE VISCOSIDAD, CONSERVANTES, ENTRE OTROS. LA COMPOSICION AL CONTENER EL ANESTESICO LOCAL EVITA EL ESTADO DE SENSACION DESAGRADABLE, LAGRIMAS, AUMENTO DE LA RESISTENCIA RESPIRATORIA NASAL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10118306A DE10118306A1 (de) | 2001-04-12 | 2001-04-12 | Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20021035A1 true PE20021035A1 (es) | 2002-11-29 |
Family
ID=7681379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000303A PE20021035A1 (es) | 2001-04-12 | 2002-04-11 | Composiciones que contienen imidazotriazinona para administracion nasal |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6740306B2 (es) |
| EP (1) | EP1381368A2 (es) |
| JP (1) | JP2004525968A (es) |
| KR (1) | KR20030087072A (es) |
| CN (1) | CN1537004A (es) |
| AR (1) | AR035821A1 (es) |
| BG (1) | BG108245A (es) |
| BR (1) | BR0208813A (es) |
| CA (1) | CA2443639A1 (es) |
| CZ (1) | CZ20032752A3 (es) |
| DE (1) | DE10118306A1 (es) |
| DO (1) | DOP2002000373A (es) |
| EC (1) | ECSP034795A (es) |
| EE (1) | EE200300501A (es) |
| GT (1) | GT200200070A (es) |
| HU (1) | HUP0303877A3 (es) |
| IL (1) | IL158255A0 (es) |
| MX (1) | MXPA03009314A (es) |
| NO (1) | NO20034556L (es) |
| PE (1) | PE20021035A1 (es) |
| PL (1) | PL363033A1 (es) |
| RU (1) | RU2003133143A (es) |
| SK (1) | SK12682003A3 (es) |
| UY (1) | UY27256A1 (es) |
| WO (1) | WO2002083674A2 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4540295B2 (ja) * | 2001-05-09 | 2010-09-08 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | ２−フェニル置換イミダゾトリアジノンの新しい用途 |
| DE102004023069A1 (de) * | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil |
| CN101083984B (zh) * | 2004-12-23 | 2010-11-10 | 罗克斯罗制药公司 | 用于经鼻内投与酮咯酸（ketorolac）的治疗组合物 |
| DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
| DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
| DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
| EP1898879A1 (en) * | 2005-06-23 | 2008-03-19 | Schering Corporation | Rapidly absorbing oral formulations of pde5 inhibitors |
| SG166106A1 (en) * | 2005-09-29 | 2010-11-29 | Bayer Schering Pharma Ag | Pde inhibitors and combinations thereof for the treatment of urological disorders |
| WO2008151734A1 (en) * | 2007-06-13 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | Pde inhibitors for the treatment of hearing impairment |
| KR20110017433A (ko) * | 2008-06-13 | 2011-02-21 | 록스로 파마 인코퍼레이티드 | 비강내 투여용 케토로락의 약학적 제형물 |
| US8551454B2 (en) * | 2009-03-13 | 2013-10-08 | Luitpold Pharmaceuticals, Inc. | Device for intranasal administration |
| US8277781B2 (en) * | 2009-03-13 | 2012-10-02 | Luitpold Pharmaceuticals, Inc. | Device for intranasal administration |
| WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
| WO2020006606A1 (en) * | 2018-07-05 | 2020-01-09 | Helium 3 Resources Pty Ltd | A pharmaceutical composition and method of use of same |
| SE542968C2 (en) * | 2018-10-26 | 2020-09-22 | Lindahl Anders | Treatment of osteoarthritis |
| IL298432A (en) * | 2020-05-26 | 2023-01-01 | Strategic Drug Solutions Inc | Formulations and methods for treating erectile dysfunction |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4602099A (en) * | 1973-04-02 | 1986-07-22 | Merrell Dow Pharmaceuticals Inc. | Antirhinovirus agents |
| GB9013750D0 (en) | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
| GB9301192D0 (en) | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
| GB9514465D0 (en) | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Chemical compounds |
| GB9514473D0 (en) | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Chemical compounds |
| EP0985671B1 (en) | 1996-05-31 | 2003-04-02 | Mochida Pharmaceutical Co., Ltd. | PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT |
| GB2315673A (en) * | 1996-08-01 | 1998-02-11 | Merck & Co Inc | Treatment of migraine |
| WO1998053819A1 (fr) * | 1997-05-29 | 1998-12-03 | Mochida Pharmaceutical Co., Ltd. | Agent therapeutique destine a traiter l'anerection |
| AU9214498A (en) | 1997-09-23 | 1999-04-12 | Eli Lilly And Company | Treatment of attention-deficit/hyperactivity disorder |
| HU230154B1 (hu) | 1997-11-12 | 2015-09-28 | Bayer Intellectual Property Gmbh | Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására |
| TWI223598B (en) * | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
| WO2000000199A1 (en) * | 1998-06-26 | 2000-01-06 | Nastech Pharmaceutical Company, Inc. | Nasal delivery of sildenafil citrate |
| CN1149983C (zh) * | 1998-12-14 | 2004-05-19 | 赛勒吉药物股份有限公司 | 用于治疗肛门直肠病的组合物和方法 |
-
2001
- 2001-04-12 DE DE10118306A patent/DE10118306A1/de not_active Withdrawn
-
2002
- 2002-04-03 HU HU0303877A patent/HUP0303877A3/hu unknown
- 2002-04-03 WO PCT/EP2002/003663 patent/WO2002083674A2/de not_active Application Discontinuation
- 2002-04-03 EE EEP200300501A patent/EE200300501A/xx unknown
- 2002-04-03 RU RU2003133143/15A patent/RU2003133143A/ru not_active Application Discontinuation
- 2002-04-03 SK SK1268-2003A patent/SK12682003A3/sk unknown
- 2002-04-03 BR BR0208813-4A patent/BR0208813A/pt not_active Application Discontinuation
- 2002-04-03 MX MXPA03009314A patent/MXPA03009314A/es unknown
- 2002-04-03 PL PL02363033A patent/PL363033A1/xx not_active Application Discontinuation
- 2002-04-03 KR KR10-2003-7013280A patent/KR20030087072A/ko not_active Application Discontinuation
- 2002-04-03 CA CA002443639A patent/CA2443639A1/en not_active Abandoned
- 2002-04-03 CN CNA028114574A patent/CN1537004A/zh active Pending
- 2002-04-03 EP EP02732548A patent/EP1381368A2/de not_active Withdrawn
- 2002-04-03 JP JP2002581429A patent/JP2004525968A/ja active Pending
- 2002-04-03 IL IL15825502A patent/IL158255A0/xx unknown
- 2002-04-03 CZ CZ20032752A patent/CZ20032752A3/cs unknown
- 2002-04-04 DO DO2002000373A patent/DOP2002000373A/es unknown
- 2002-04-10 AR ARP020101322A patent/AR035821A1/es not_active Application Discontinuation
- 2002-04-11 US US10/122,694 patent/US6740306B2/en not_active Expired - Fee Related
- 2002-04-11 GT GT200200070A patent/GT200200070A/es unknown
- 2002-04-11 UY UY27256A patent/UY27256A1/es not_active Application Discontinuation
- 2002-04-11 PE PE2002000303A patent/PE20021035A1/es not_active Application Discontinuation
-
2003
- 2003-10-08 EC EC2003004795A patent/ECSP034795A/es unknown
- 2003-10-09 BG BG108245A patent/BG108245A/xx unknown
- 2003-10-10 NO NO20034556A patent/NO20034556L/no not_active Application Discontinuation
-
2004
- 2004-03-30 US US10/813,801 patent/US20040248891A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| UY27256A1 (es) | 2002-11-29 |
| IL158255A0 (en) | 2004-05-12 |
| DOP2002000373A (es) | 2002-11-30 |
| HUP0303877A3 (en) | 2005-05-30 |
| JP2004525968A (ja) | 2004-08-26 |
| HUP0303877A2 (hu) | 2004-03-29 |
| WO2002083674A3 (de) | 2003-01-09 |
| SK12682003A3 (sk) | 2004-03-02 |
| EE200300501A (et) | 2003-12-15 |
| NO20034556D0 (no) | 2003-10-10 |
| NO20034556L (no) | 2003-12-10 |
| WO2002083674A2 (de) | 2002-10-24 |
| AR035821A1 (es) | 2004-07-14 |
| ECSP034795A (es) | 2003-12-01 |
| BG108245A (en) | 2005-01-31 |
| CA2443639A1 (en) | 2002-10-24 |
| KR20030087072A (ko) | 2003-11-12 |
| EP1381368A2 (de) | 2004-01-21 |
| US20040248891A1 (en) | 2004-12-09 |
| GT200200070A (es) | 2003-01-31 |
| CZ20032752A3 (cs) | 2004-01-14 |
| DE10118306A1 (de) | 2002-10-17 |
| PL363033A1 (en) | 2004-11-15 |
| MXPA03009314A (es) | 2004-03-10 |
| RU2003133143A (ru) | 2005-04-10 |
| US20030022894A1 (en) | 2003-01-30 |
| US6740306B2 (en) | 2004-05-25 |
| BR0208813A (pt) | 2004-03-09 |
| CN1537004A (zh) | 2004-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20021035A1 (es) | Composiciones que contienen imidazotriazinona para administracion nasal | |
| EA200401056A1 (ru) | Комбинация, содержащая производные тропана, полезные в терапии | |
| ATE450260T1 (de) | Therapeutische zusammensetzungen enthaltend 1,2,3,6-tetrahydropyrimidin-2-one und entsprechende methoden | |
| ECSP024364A (es) | Antagonistas receptores de adenosina a2a | |
| PA8610801A1 (es) | Compuestos de aril o heteroaril amida | |
| AR041566A1 (es) | Derivados de indol utiles para el tratamiento de enfermedades | |
| ES2175480T3 (es) | Composiciones limpiadoras y desinfectantes mejoradas, de tipo eflorescente. | |
| PE20090733A1 (es) | Derivados de pirazina como bloqueadores de los canales de sodio epitelial | |
| PE20081493A1 (es) | Nuevos derivados de 1,4-benzotiepina-1,1-dioxido sustituidos con radicales bencilo, metodo para su preparacion, productos farmaceuticos que comprenden estos compuestos y su uso | |
| AP2001002307A0 (en) | B3 adrenergic receptor agonists and uses thereof. | |
| AR076859A1 (es) | Derivados de 1,2,4-triazolo[4,3-a]piridina moduladores alostericos positivos de receptores mglur2 , composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos neurologicos y siquiatricos. | |
| HUP0203872A2 (hu) | Helyettesített 4-(fenil-N-alkil)-piperazin és piperidinszármazékok, alkalmazásuk dopamin neurotranszmissziós modulátorként és ezeket tartalmazó gyógyszerkészítmények | |
| AR013454A1 (es) | Metodo para el tratamiento de las enfermedades pulmonares con 5'-difosfato de uridina y analogos del mismo, composiciones formuladas con dichos compuestosy los compuestos mencionados. | |
| AR076860A1 (es) | Derivados de 7-aril- 1,2,4-triazolo[4,3-a]piridina moduladores alostericos positivos de receptores mglur2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos neurologicos y siquiatricos. | |
| BR9704937A (pt) | Derivados de diamino-1,3,5-triazina substituìda | |
| HUP0300444A2 (hu) | Kálciumblokkolót tartalmazó stabilizált gyógyszerkészítmények | |
| HK1079526A1 (en) | A novel pyrazine compound and its use in the manufacture of a medicament for treating diseases related to serotonin | |
| AR076362A1 (es) | Arilsulfonamidas 2,5-disustituidas antagonistas de ccr3, composiciones farmaceuticas que las contienen y uso de las mismas para el tratamiento y/o prevencion de patologias autoinmunes e inflamatorias, entre otras. | |
| HUP0100024A2 (hu) | Alzheimer-kór kezelésére szolgáló hatóanyagként karvedilolszármazékokat tartalmazó gyógyszerkészítmények | |
| NO20033959D0 (no) | Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon | |
| BR0107978B1 (pt) | composição compreendendo cera de vela estabilizada por uma combinação de absorvente de radiação uv mais uma amina impedida selecionada. | |
| ATE273277T1 (de) | Piperidinyl- und n-amidinopiperidinyl-derivate | |
| AR048112A1 (es) | Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor | |
| PE20211218A1 (es) | Suspensiones liquidas de paracetamol | |
| CY1110572T1 (el) | Στοματικο αντικαταθλιπτικο σκευασμα το οποιο περιλαμβανει ακετυλοσαλικυλικο οξυ για επιταχυνση της εναρξης δρασης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |